EUR/USD
1.15382
-0.401%
Gold
3440.89
1.600%
Oil
72.386
7.164%
USD/JPY
144.536
0.742%
GBP/USD
1.35459
-0.493%
GBP/JPY
195.790
0.275%
Real-time News
On June 16, CICC pointed out that in the first half of 2025, although policy uncertainty has increased significantly, the global economy as a whole is running smoothly, and other major central banks except the Federal Reserve continue to cut interest rates. In the second half of the year, the economic momentum of the United States and non-US regions will converge, mainly driven by the slowdown in the US economy. Non-US regions have certain advantages due to relatively loose monetary policies and room for repair of output gaps, but the extent of repair in the second half of the year is constrained by high policy uncertainty and the front-end of exports and growth in the first half of the year. Against this background, we are more optimistic about opportunities in non-US regions in the second half of the year, remain relatively optimistic about the European market, and increase the weight of emerging markets. However, we believe that the differentiation of regional performance may be smaller than in the first half of the year, and we recommend a balanced allocation.Market News: The Swiss Embassy, which represents US interests in Tehran, has been closed until further notice.According to Iranian media Rouydad24: In the early hours of Monday local time, the air defense system near the Pasteur Center area was activated. This area is the official residence of Irans supreme leader and president.On June 16, WuXi Biologics announced on the Hong Kong Stock Exchange that on June 14, the companys board of directors was informed by one of the companys major shareholders that it had entered into a block transaction agreement with Morgan Stanley International plc, pursuant to which the placing agent has agreed to place 82,940,000 existing shares of the company held by Biologics Holdings (equivalent to approximately 2.04% of the total issued share capital of the company as of the date of this announcement) at a price of HK$26.60 per share to parties independent of and not connected with the company. Note: WuXi Biologics (02269.HK)s latest closing price is HK$28.On June 16, the article stated that protecting the rights of car owners is a must-answer question for the development of the automobile industry. Looking forward to the future of new energy vehicles, technological progress and consumer rights protection will surely move forward in tandem. All parties work together to build a comprehensive and multi-level rights protection network, so that consumers can buy and use cars with peace of mind, which will surely continue to inject confidence and motivation into the high-quality development of the new energy vehicle industry.
